A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients

Mari Eriksson; Helena Käyhty; Mika Lahdenkari; Heikki Makisalo; Veli-Jukka Anttila

doi:10.1016/j.vaccine.2021.03.063

A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients

Mari Eriksson, Helena Käyhty, Mika Lahdenkari, Heikki Makisalo, Veli-Jukka Anttila

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Vaccine
Volume	39
Issue number	17
Pages (from-to)	2351-2359
Number of pages	9
ISSN	0264-410X
DOIs	https://doi.org/10.1016/j.vaccine.2021.03.063
Publication status	Published - 22 Apr 2021
MoE publication type	A1 Journal article-refereed

Fields of Science

Pneumococcal disease
Pneumococcal vaccination
Liver transplant recipients
3121 General medicine, internal medicine and other clinical medicine

Access to Document

10.1016/j.vaccine.2021.03.063

Cite this

Eriksson, M., Käyhty, H., Lahdenkari, M., Makisalo, H., & Anttila, V.-J. (2021). A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients. Vaccine, 39(17), 2351-2359. https://doi.org/10.1016/j.vaccine.2021.03.063

@article{63efc85ec4234675931e09a121133ca6,

title = "A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients",

keywords = "Pneumococcal disease, Pneumococcal vaccination, Liver transplant recipients, 3121 General medicine, internal medicine and other clinical medicine",

author = "Mari Eriksson and Helena K{\"a}yhty and Mika Lahdenkari and Heikki Makisalo and Veli-Jukka Anttila",

year = "2021",

month = apr,

day = "22",

doi = "10.1016/j.vaccine.2021.03.063",

language = "English",

volume = "39",

pages = "2351--2359",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd. ",

number = "17",

}

Eriksson, M, Käyhty, H, Lahdenkari, M, Makisalo, H & Anttila, V-J 2021, 'A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients', Vaccine, vol. 39, no. 17, pp. 2351-2359. https://doi.org/10.1016/j.vaccine.2021.03.063

A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients. / Eriksson, Mari; Käyhty, Helena; Lahdenkari, Mika et al.
In: Vaccine, Vol. 39, No. 17, 22.04.2021, p. 2351-2359.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients

AU - Eriksson, Mari

AU - Käyhty, Helena

AU - Lahdenkari, Mika

AU - Makisalo, Heikki

AU - Anttila, Veli-Jukka

PY - 2021/4/22

Y1 - 2021/4/22

KW - Pneumococcal disease

KW - Pneumococcal vaccination

KW - Liver transplant recipients

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1016/j.vaccine.2021.03.063

DO - 10.1016/j.vaccine.2021.03.063

M3 - Article

SN - 0264-410X

VL - 39

SP - 2351

EP - 2359

JO - Vaccine

JF - Vaccine

IS - 17

ER -